VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $62,000 | +1966.7% | 3,100 | +3000.0% | 0.03% | +2500.0% |
| Q1 2016 | $3,000 | -96.2% | 100 | -87.2% | 0.00% | -96.7% |
| Q4 2015 | $80,000 | -52.9% | 780 | -22.0% | 0.03% | -53.1% |
| Q3 2015 | $170,000 | -23.8% | 1,000 | 0.0% | 0.06% | -15.8% |
| Q2 2015 | $223,000 | +11.5% | 1,000 | 0.0% | 0.08% | +13.4% |
| Q1 2015 | $200,000 | +39.9% | 1,000 | 0.0% | 0.07% | +28.8% |
| Q4 2014 | $143,000 | +9.2% | 1,000 | 0.0% | 0.05% | +4.0% |
| Q3 2014 | $131,000 | +4.0% | 1,000 | 0.0% | 0.05% | -3.8% |
| Q2 2014 | $126,000 | -4.5% | 1,000 | 0.0% | 0.05% | -5.5% |
| Q1 2014 | $132,000 | +12.8% | 1,000 | 0.0% | 0.06% | +1.9% |
| Q4 2013 | $117,000 | +12.5% | 1,000 | 0.0% | 0.05% | -14.3% |
| Q3 2013 | $104,000 | +20.9% | 1,000 | 0.0% | 0.06% | +10.5% |
| Q2 2013 | $86,000 | – | 1,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |